AIM ImmunoTech

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-04-30 2024-03-31
Revenue
$35
$50
$40
$40
Gross Profit
27
42
-26
-26
EBITDA
-3,435
-1,595
-5,676
-5,687
EBIT
-3,498
-1,656
-5,734
-5,745
Net Income
-3,700
-1,836
-5,817
-5,817
Net Change In Cash
35
50
40
40
Free Cash Flow
-3,268
-3,237
-4,865
-4,865
Cash
915
3,554
3,295
3,295
Basic Shares
57,677
52,837
49,458
49,458

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$202
$141
$135
$163
Gross Profit
160
-19,782
-715
-643
EBITDA
-31,678
-19,869
-18,255
-13,022
EBIT
-31,916
-19,445
-19,060
-13,728
Net Income
-28,962
-21,086
-21,513
-16,258
Net Change In Cash
202
141
135
163
Free Cash Flow
-21,852
-16,379
-14,598
-10,963
Cash
5,439
27,053
32,093
38,501
Basic Shares
48,585
48,047
47,339
31,842

Earnings Calls

Quarter EPS
2024-09-30
-$0.06
2024-06-30
-$0.04
2024-04-30
-$0.12
2024-03-31
-$0.26